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Abstract: Lack of better understanding of nanoparticles targeted delivery 
into cancer cells calls for advanced optical microscopy methodologies. Here 
we  present  a  development  of  fluorescence  microspectroscopy  (spectral 
imaging) based on a white light spinning disk confocal microscope with 
emission  wavelength  selection  by  a  liquid  crystal  tunable  filter.  Spectral 
contrasting of images was used to localize polymer nanoparticles and cell 
membranes labeled  with fluorophores that have substantially overlapping 
spectra.  In  addition,  fluorescence  microspectroscopy  enabled  spatially-
resolved  detection  of  small  but  significant  effects  of  local  molecular 
environment on the properties of environment-sensitive fluorescent probe. 
The observed spectral shift suggests that the delivery of suitably composed 
cancerostatic alkylphospholipid nanoparticles into living cancer cells might 
rely on the fusion with plasma cell membrane. 
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1. Introduction 
Nanoparticles  have  reduced  renal  clearance  and  therefore  remain  in  the  blood  circulation 
longer compared to compounds with lower molecular weight. Due to compromised vascular 
endothelial  lining  and  the  lack  of  lymphatic  drainage  they  accumulate  in  the  tumor 
environment  [1].  Consequently,  different  nanoparticles,  for  example  polymer-based,  lipid-
based,  metal-based,  and  carbon-based  nanoparticles,  are  increasingly  being  employed  in 
cancer therapy [1]. The described enhanced permeability and retention effect can be exploited 
for  passive  targeting  of  high  molecular  weight  compounds  and  small  particles  to  tumors, 
which is currently considered as an effective way to bring drugs to tumors [2]. However, the 
efficient interaction of nanoparticles with cancer cells, e.g. through drug release in case of 
nanocarriers or through cellular uptake of nanoparticles, is as crucial as their accumulation 
around cells. Thus, it is important to develop advanced approaches to study mechanisms of 
nanoparticles delivery into cells. 
In our previous work we have shown that the interaction of nanosized liposomes, made of 
cancerostatic alkylphospholipid [3] and cholesterol, with breast cancer cells depends critically 
on liposome membrane composition and membrane fluidity characteristics [4]. Although a 
#146260 - $15.00 USD Received 21 Apr 2011; revised 3 Jun 2011; accepted 27 Jun 2011; published 29 Jun 2011
(C) 2011 OSA 1 August 2011 / Vol. 2,  No. 8 / BIOMEDICAL OPTICS EXPRESS  2084   
comprehensive  membrane  characterization  based  on  electron  paramagnetic  resonance 
spectroscopy  with  spin  labeling  provided  detailed  information  about  overall  membrane 
properties, it could not give spatial information about liposome-cell interaction. To gain new 
insight  confocal  fluorescence  microscopy  was  used,  since  it  enables  localization  of 
fluorescently labeled lipid nanoparticles. 
Confocal  fluorescence  microscopy  has  become  invaluable  for  a  wide  range  of 
investigations due to its capability of imaging thin optical sections [5]. It is a convenient tool 
for localization of labeled regions within a sample, but it offers only limited information on 
their  molecular  properties.  In  addition,  it  does  not  allow  differentiating  between  regions 
labeled with fluorescent probes with substantially overlapping spectra or sampling multiple 
spectral parameters simultaneously to understand the interactions of individual components 
within complex matrices. To overcome the shortcomings of confocal fluorescence microscopy 
spectral imaging or fluorescence microspectroscopy (FMS) has been introduced [6,7]. It has 
to be noted that there exist  also label-free  microscopy and  microspectroscopy alternatives 
such as Raman microspectroscopy [8]. The label-free techniques are advantageous when the 
introduction of fluorescent labels and their instability pose a problem. 
Confocal FMS indicates coupling of confocal fluorescence microscopy and spectroscopy. 
It allows acquisition of fluorescence spectra from particular volume elements in a sample. 
This technique has already proved to be a biomedically relevant methodology e.g. in drug 
screening [9], in studying cell transfection by liposomal formulation of siRNA [10], or in 
fluorescence tomography [11]. In the present work it will be shown that FMS methodology 
can be successfully applied also to the study of the mechanism of nanoparticles delivery into 
living  cancer  cells  providing  invaluable  information  that  cannot  be  obtained  with  other 
methods. 
In order to make FMS widely accessible to the biomedical community the system has to 
be affordable and should permit routine use. Here we report about such development of an 
FMS system based on a white light spinning disk confocal microscope. The spinning disk 
confocal  microscopy  is  appropriate  for  cell  imaging  due  to  reduced  fluorophore 
photobleaching problem as well as for a high image acquisition rate [12,13]. Moreover, the 
use of a broad-spectrum arc-lamp excitation (white light) source enables flexibility needed 
with respect to different problem-specific fluorescent probes as well as their synthesis-on-
demand [14]. The white light FMS system is also in line with the current developments and 
ambitions focused to new fluorophore design with less limitation in the choice of excitation or 
emission wavelengths. 
The  developed  FMS  setup  is  an  example  of  a  filter-based  system.  Specifically,  the 
emission wavelength selection is done with a narrow band liquid crystal tunable filter (LCTF) 
placed in front of the camera. A similar approach was used before [15], where however the 
LCTF was applied to resolve the weights of spectral components of different probes via linear 
unmixing  and  not  for  the  detection  of  small  lineshape  changes  in  combination  with 
environmentally sensitive probes. In similar manner to LCTF also acousto-optic tunable filters 
can  be  used  [16].  Both  filter  technologies  provide  very  fast  wavelength  selection  and 
tunability while preserving image integrity with the advantage of having no moving parts. 
Beside the filter-based FMS systems, there are also interferometric, grating-based or optical-
fiber-array-based systems [17,18]. 
The main advantage of our FMS system is its modular structure, which enables upgrade of 
any fluorescence microscope to a confocal FMS system at a relatively low cost and with a 
good spectral resolution. Since the system is flexible it can easily be optimized for different 
research problems. 
In this paper we examine the mechanism of delivery of different fluorescently labeled 
nanoparticles  into  cancer  cells  by  spectrally  contrasting  FMS  images.  The  spectral 
information  is  obtained  through  automated  analysis  in  terms  of  intensities  and  emission 
spectra maximum wavelengths from every pixel in FMS images. The application of a narrow 
band pass filter, i.e. LCTF, enabled us to localize and differentiate labeled nanoparticles and 
cell  membranes  although  their  spectra  overlap.  Moreover,  the  interaction  of  fluorescently 
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labeled nanoparticles with non-labeled cells has been also revealed through the influence of 
probes' local molecular environment on the spectral shape. The presented results point to the 
biomedical potential of the presented FMS setup. 
2. Materials and methods 
2.1. Test fluorescent beads 
FocalCheck fluorescent beads (F36913, Invitrogen, Carlsbad, CA, USA) were chosen as a test 
sample.  The  convenience  of  this  sample  as  a  stable  and  repeatable  standard  has  been 
demonstrated  recently  [19].  The  test  slide  with  immobilized  fluorescent  beads  (6  μm  in 
diameter)  stained  with  two  spectrally  closely  overlapping  orange  dyes  was  used.  The 
excitation/emission maxima declared by the producer for these dyes are 541/555 and 545/565 
nm, respectively. The FMS images were taken in 2 nm steps in the interval from 536 to 630 
nm, exposure time being 500 ms for each of them. The maximum level of counts on the CCD 
detector was around 340 counts/s. 
2.2. Interaction of cancer cells with fluorescently labeled nanoparticles 
Human breast adenocarcinoma cell line MCF-7 cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM, Gibco, Invitrogen, Carlsbad, CA, USA) containing 10% fetal calf 
serum (FSC) and 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma-Aldrich Chemie 
GmbH, Steinheim, Germany). The cells were incubated at 37°C in a humidified 5% CO2 
atmosphere. 
For fluorescence microspectroscopy experiments on the interaction of living cancer cells 
with different nanoparticles, cells were plated on glass-bottom cell culture dishes (Chambered 
Coverglass, Lab-Tek, Nalge Nunc, Rochester, NY) and allowed to grow for one day. The 
number of cells was approximately 30000 cells/well before the experiments. 
In the experiments with fluorescein labeled polystyrene latex nanoparticles (Fluoresbrite 
YG microspheres, Polysciences GmbH, Eppelheim, Germany) of 50 nm diameter, 5 μl of 3.7 
× 10
12 particles/ml were incubated with cells for 20 minutes. For polymer nanoparticles with 
500 nm diameter, 0.1 μl of 3.7 × 10
11 particles/ml was used. These nanoparticles have the 
fluorescence  emission  maximum  at  486  nm  and  an  additional  shoulder  with  intensity 
comparable  to  the  maximum  at  around  515  nm,  as  declared  by  the  producer.  In  our 
experiments the latter shoulder was monitored. 
Afterwards 1 μl of 10
4 M or 5 μl of 10
3 M (dissolved in DMSO) lipophilic fluorescent 
probe NBD-FA was added to the cells in case of 50 nm or 500 nm nanoparticles, respectively. 
The different amount of lipophilic probe was used in order to approximately match the level 
of fluorescence emission by polymer nanoparticles in different cases. This precaution enabled 
contrasting between the label bound to the nanoparticles and the label in the cell membrane. 
Consequently, the exposure time of 500 ms for one optical slice at a single wavelength for 500 
nm nanoparticles was increased to 20 s in the case of 50 nm nanoparticles when recording 
images in confocal mode. The maximum level of counts on the CCD detector in the regions 
free from aggregated nanoparticles was around 30 counts/s and 3 counts/s, respectively. The 
exposure time was 1 s for 50 nm nanoparticles in the wide-field mode with the maximum 
level of counts around 50 counts/s. The FMS images were taken in 3 nm steps in the interval 
from 470 to 551 nm. 
NBD-FA probe was synthesized, as described earlier [14], by combining an amino sugar, 
which serves as a central polar group, NBD and the derivative of the fatty acid. The probe is 
labeled “16b” in the reference [14]. The measured emission maximum of this probe in a lipid 
environment was about 537 nm. Next, the time evolution of samples was followed with FMS. 
In the experiments with lipid nanoparticles the cell medium was replaced with 200 μl PBS 
and then 10 μl of prepared labeled liposomes were added and incubated with the cultured 
cells. Next, the time evolution of samples was followed with FMS. The exposure time was 
500 ms for single wavelength. The maximum level of counts on the CCD detector was around 
260 counts/s for lipid nanoparticles with lower concentration of cholesterol and 80 counts/s 
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for  nanoparticles  with  higher  level  of  cholesterol.  Due  to  considerable  photobleaching  of 
NBD-PC probe the FMS images were taken in 5 nm steps, so that fewer exposures were 
needed to obtain the whole spectrum. The spectral range was from 515 to 585 nm. 
2.3. Preparation of fluorescently labeled liposomes 
Large unilamellar vesicles (LUV) were prepared from octadecyl-(N,N-dimethyl-piperidino-4-
yl)-phosphate (OPP), cholesterol (Chol) and dicetylphosphate (DCP), as described previously 
[20]. Briefly, multilamellar vesicles (MLV), final concentration 10 mM, were prepared by the 
lipid film/hydration method from appropriate mixtures of stock solutions of the components in 
CH3Cl/MeOH (7:3, v/v). The lipid film was resuspended in phosphate buffer saline (PBS). 
LUV were prepared from MLV by repeated extrusion through polycarbonate filters (diameter 
of pores, 100 nm) using a  LiposoFast Basic system (Avestin,  Ottawa, ON,  Canada).  The 
molar ratio between OPP and DCP was kept constant (10:2), while the molar ratio between 
OPP  and  Chol  was  different  for  different  liposomes.  In  OPP5  LUV  the  molar  ratio  of 
OPP:Chol was 10:5 and in OPP15 the molar ratio was 10:15. The negatively charged DCP 
was used to prevent aggregation of LUV. 
LUV were fluorescently labeled with a phospholipid fluorescent probe NBD-PC, where 7-
nitrobenz-2-oxa-1,3-diazol-4-yl  (NBD)  is  attached  to  a  phosphatidylcholine  phospholipid 
(16:0-06:0 NBD PC, Avanti polar lipids, Alabaster, AL, USA). NBD-PC was added to the 
organic solvent before preparing MLV. The fluorescence emission maximum of this probe 
declared by the producer is around 534 nm. The molar concentration of the fluorescent probe 
with respect to other components was 0.5 mol%. 
The  reference  measurements  of  fluorescence  emission  spectra  were  done  with  Infinite 
M1000 microplate reader (Tecan, Männendorf, Switzerland). A 96-well black plate was used 
in the fluorescence intensity top mode. 
2.4. Confocal fluorescence microspectroscopy system 
The confocal FMS system, presented in  Fig. 1, is built on an inverted microscope Nikon 
Eclipse  TE  2000-E  platform.  Unless  specified  otherwise,  an  oil  immersion  100x  1.4-NA 
objective lens was used in this work to provide high magnification and high spatial resolution. 
The  microscope  is  equipped  with  a  Prior  ProScan  II  (Cambridge,  UK)  motorized  and 
computer  controlled  stage  that  enables  precise  movements  of  the  sample  in  the  x  and  y 
directions (in the plane perpendicular to the optical axis of the objective). Focus is controlled 
with  a  stepper  motor  for  objective  holders,  which  enables  optical  sectioning  along  the  z 
direction (along the optical axis). The confocal unit is a CARV II spinning disk confocal 
module (BD Biosciences, Franklin Lakes, NJ, USA), which also houses excitation, dichroic 
and emission filters (BrightLine filters from Semrock, Rochester, NY, USA). As an excitation 
source a high power 300 W xenon Lambda LS arc-lamp (Sutter, Novato, CA, USA) is used. 
The advantage of this kind of source is a broad spectrum of emitted light, which provides 
flexibility  with  respect  to  the  wavelength  of  excitation  light.  All  electronic  microscope 
functions as well as camera control, shutters, stage, and focus, are controlled using a home-
built software. 
The fluorescence emission light that leaves the CARV unit can be directed to the camera 
in two ways. In the microspectroscopy mode the light goes through the liquid crystal tunable 
filter (LTCF) [21,22] (Fig. 1a). In the other alternative, the light goes directly to the camera by 
inserting the movable mirrors for conventional microscopy operation (Fig. 1b). The lenses in 
the latter option are used to correct for the focus shift produced by passing light through the 
LCTF. In our case the geometrical constraints and the degree of the focus shift due to LCTF 
prompted us to use in turn achromatic convergent lens with the focal length of 10 cm and an 
achromatic divergent lens with the focal length of 5 cm. The magnification of this double lens 
combination  is  approximately  1.5,  which  is  matched  on  the  first  path  by  using  the  1.5x 
magnification optovar in the Nikon microscope. 
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Fig. 1.  A schematic presentation of the configuration of the experimental setup. The light 
coming from the spinning disk confocal module can be directed to the camera in two different 
paths by moving two mirrors (indicated by the double-headed arrows) in or out of the optical 
path.  The  first  path  (a)  where  the  light  goes  through  the  LCTF  represents  the  (confocal) 
fluorescence microspectroscopic mode while the second path (b) represents the conventional 
(confocal) fluorescence microscopy imaging mode. 
The microspectroscopic images are taken successively at different wavelengths, i.e. as a 
wavelength  stack  or  λ-stack.  The  LCTF  is  Varispec  VIS-10-20  from  CRi  (Woburn,  MA, 
USA), tunable in the range from 400 to 720 nm, with the bandwidth of around 10 nm. The 
uncertainty in setting the wavelength value of LCTF is about 1 nm. Both the wavelength 
accuracy and the LCTF bandwidth are well below the fluorescence emission spectral width, 
thus exhibiting very low distortion on the acquired emission spectra. The wavelength can be 
changed in the order of a few tens of milliseconds. 
The  last  component  in  the  system  is  a  highly  sensitive  QImaging  Rolera  MGi  back-
illuminated EMCCD (Electron Multiplying Charge-Coupled Device) (Surrey, BC, Canada) 
camera  with a  very  high quantum efficiency (>90% between 500 and 700 nm),  which is 
needed  mainly  because  of  the  light  intensity  losses  due  to  spinning  disk  and  LCTF.  The 
detector has 512x512 pixels with 16 μm pixel size. The image size on the detector matches the 
part  of  homogeneously  illuminated  section  of  the  sample.  The  detector  field  of  view 
determines the size of a single image pixel to about 100 nm x 100 nm, which does not exceed 
half of the wavelength. The EM assures adequate signal to noise ratios also at fast image 
acquisition rate enabled by the spinning disk confocal microscope. 
The measured radiant output from the liquid light guide connected to the xenon lamp is 
around 450 mW being reduced to around 25 mW when light reaches the sample. In confocal 
mode  spinning  disk  reduces  the  value  by  additional  92%  (measured  value),  yielding 
approximately 2 mW of excitation power or 10
16 photons/s. Assuming the number of dye 
molecules in a volume element of a sample to be around 1000 (corresponding to 10
5 M probe 
solution or 1 probe per 200 lipid molecules in a vertical membrane bilayer) and taking into 
account typical extinction coefficient and quantum efficiency (2 × 10
4 (M cm)
–1, and 0.3, 
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respectively), their fluorescent output is around 2.0 × 10
6 and 1.5 × 10
5 photons/s in wide-
field and confocal mode, respectively. Considering objective acceptance angle, dichroic and 
emission filter transmittances, LCTF characteristics, and camera quantum efficiency, around 
8000 or 600 photons/s are finally detected within 10 nm LCTF-filtering window in wide-field 
or confocal mode, respectively. Consequently, the number of counts on the CCD detector will 
be in the range of hundred counts/s or ten counts/s after AD conversion in  wide-field or 
confocal  mode,  respectively.  This  can  be  increased  mainly  by  more  efficient  probe  or 
increased probe concentration. 
In our system the typical spectral acquisition time for single optical slice is in the range of 
minutes.  In  comparison,  typical  acquisition  times  in  wavelength  dispersive  systems  for 
512x512 pixels image range from seconds to tens of minutes [23,24]. The main advantage of 
an  LCTF-based  system  over  systems  with  simultaneous  channels  relies  on  the  spectral 
resolution at desired sensitivity. The latter system working in a broad spectral range (e.g. 32 
channels and 300 nm spectral range) provides resolution of 10 nm at a channel width of 10 
nm. With respect to a typical fluorescence spectrum span of about 80 nm, such a device 
provides only 8 points characterizing the emission spectrum. An LCTF-based system can be 
adjusted to 1 nm steps with 10 nm filter width, providing better resolution at a comparable 
sensitivity. Note, that the distortion of a lineshape is still small since the linewidth is much 
larger than 10 nm. On the contrary, when working in a narrow spectral range, like 30-60 nm, a 
32  channel  system  would  have  the  same  resolution  but  with  1  nm  channel  width. 
Consequently, the exposure times would have to be increased for 10 times to count the same 
amount of photons.  Similar  conclusions hold  for  wavelength dispersive  systems based on 
CCD camera, where binning increases sensitivity at a cost of lower spectral resolution. Taking 
these facts into account, we can state that our FMS system can perform better for a full-image 
high-resolution microspectroscopic analysis, while the point-scanning wavelength dispersive 
systems are advantageous in cases when just a portion of the image has to be scanned. 
2.5. Spectra acquisition and analysis 
A  home-built  program  “FMS+:  Fluorescence  MicroSpectroscopy  Acquisition,  Control, 
Processing” has been developed in MathWorks MatLab environment (Natick, MA, USA). 
The program controls the recording of images at different wavelengths and their analysis in 
order to extract fluorescence emission spectra. The program replaces the software packages 
controlling the microscope, camera and LCTF and, most importantly, allows high-throughput 
microspectroscopy experiments. The latter is not possible by independent control over the 
different components of the FMS system. 
To obtain spectra that can be directly compared to spectroscopic data acquired by other 
methods, several corrections have to be applied to the pixel intensity values measured by the 
detector. The camera dark current is corrected by acquiring two black reference images before 
and  after  the  experiment  with  the  same  camera  settings  but  without  excitation  light.  An 
average of these images is subtracted from all images in a spectral series. 
Photobleaching of the fluorophores is corrected with a similar approach by monitoring the 
intensity  of  the  signal  recorded  at  a  reference  wavelength  that  can  be  arbitrarily  chosen 
(usually  close  to  the  wavelength  of  maximal  intensity  in  the  considered  spectral  region). 
During the recording of a λ-stack six reference images are taken (one at the beginning, four 
during the recording at recurring wavelength intervals, and one at the end), and the decay of 
the intensity over the consecutive reference images is used to correct the intensities of each 
image in the λ-stack after the dark current contribution has been subtracted. 
Transmission characteristics of the LCTF as well as the EMCCD sensitivity as a function 
of wavelength are known and are utilized to correct the light intensities at each wavelength 
accordingly [15]. Since transmittances of fluorescence filters used are high (> 0.95) and nearly 
constant (with variations < ± 2%, which occur at much smaller wavelength steps than LCTF 
spectral width) in the spectral region of typical measurements, their effect on the measured 
spectra is neglected. 
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After the images in a λ-stack are corrected, as described above, a spectrally contrasted 
image is generated for a fast and intuitive visual inspection of the acquired data from the 
obtained spectra. Every point of the image is color-coded in terms of hue  [0,1  ] h  according 
to  the  wavelength  of  the  spectral  maximum  λmax,  and  in  terms  of  brightness  [0,1  ] v  
according to the level of intensity  [0,1  ] i . The latter is normalized to the maximum intensity 
in the λ-stack of images, respectively. The pixel colors are defined according to the following 
formulae: 
 
1.3 1.2
0.5 1
21
0.8 , 1, ,  1
max hv s i




           
   (1) 
where λ1 and λ2 are predefined values limiting the wavelength range of interest. Saturation is 
always kept maximal (equal to 1) for best color contrast. Values of λmax that fall outside this 
range are set to the limiting values. The exponents in Eq. (1) are introduced to enhance the 
perception of color contrast while the coefficient of 0.8 extracts violet-to-red color range from 
cyclic hue function. 
In case of low signal-to-noise ratio and small differences in the fluorescence emission 
spectrum maxima, the noise in the detected photon counts can interfere with the measurement 
of  very  small  shifts.  To  reduce  the  effect  of  noise  on  the  determination  of  λmax  position 
spectral  data  is  smoothed  by  fitting  it  with  a  third  order  polynomial.  Subsequently,  a 
normalized distribution of λmax values can be plotted for an arbitrarily chosen image region 
and the maximum of the histogram is then used as the reference emission spectrum maximum 
λmax(hist). As it can be seen from the experimental data, such a procedure reveals λmax(hist) 
accuracy  better  than  1  nm,  even  despite  lower  spectral  resolution  for  spectra  taken  with 
wavelength steps of a few nm. Note that this procedure is analogous to the single molecule 
tracking, where optical resolution of 200 nm is converted to positional accuracy of 30 nm by 
fitting the shape of the light profile [25]. 
3. Results and discussion 
3.1. Spectral contrasting of microspectroscopic image 
By  passing  the  emitted  light  through  LCTF,  FMS  system  is  running  in  the  fluorescence 
microspectroscopic  mode  (Fig.  1a).  The  FMS  mode  can  either  be  confocal  or  wide-field 
depending on the positioning of the spinning disk in the optical path. The pictures taken at 
different wavelengths are used to build a λ-stack of images (Fig. 2a). An example in Fig. 2 
shows an optical slice through two fluorescent beads. The two beads are labeled with two 
different fluorescent dyes with the declared emission maxima at 555 and 565 nm. 
The “FMS+” software enables extraction of fluorescence emission spectra from any pixel 
in the image or an average spectrum from a group of neighboring pixels (small white squares 
in Fig. 2a). As shown in Fig. 2b, test example of two fluorescent beads reveals a measured 
shift between the maxima of fluorescence emission spectra of around 9 nm, which agrees well 
with the shift of around 10 nm declared by the producer of the beads. 
The color coding transformation automatically assigns colors to pixels or groups of pixels 
across the image according to particular emission spectrum characteristics as discussed in the 
section Materials and methods. In the presented case the color coding was applied to code λmax 
with the underlying color legend (small open white squares in Fig. 2b) within the interval 
from 540 to 570 nm. Consequently, the pixels corresponding to the left fluorescent bead will 
be  colored  bright  green  in  the  final  image,  while  the  right  bead  will  be  orange/red  and 
dimmer, since the spectrum intensity is lower. In the spectrally contrasted image (Fig. 2c) 
small white squares indicate the positions that were originally chosen in the λ-stack (Fig. 2a) 
for presenting fluorescence emission spectra. 
Note that in contrast to the LCTF application of Fraser’s group [15], where LCTF is used 
to derive locally resolved spectral information of different probes linearly unmixed via known  
 
#146260 - $15.00 USD Received 21 Apr 2011; revised 3 Jun 2011; accepted 27 Jun 2011; published 29 Jun 2011
(C) 2011 OSA 1 August 2011 / Vol. 2,  No. 8 / BIOMEDICAL OPTICS EXPRESS  2090   
400 500 600 700
Wavelength
0.5
1
Intensity 1
540 560 580 600 620
I
n
t
e
n
s
i
t
y
 
(
a
.
u
.
)
Wavelength (nm)
540 nm
560 nm
580 nm
600 nm
620 nm
540 nm
560 nm
580 nm
600 nm
620 nm
(a) Wavelength (lambda) stack
(b) Fluorescence emission spectra
(c) Spectrally contrasted image
and Color coding
max = 9 nm
10 m
 
Fig.  2.  Spectral  contrasting  of  a  microspectroscopic  image.  (a)  Fluorescence 
microspectroscopic mode provides a stack of images obtained at different wavelength settings 
of the LCTF (a λ-stack of images) in FMS system. Different regions of interest can be selected 
from which (b) fluorescence emission spectra are extracted. The spectra are used in the color 
coding procedure to provide (c) a spectrally contrasted image, in this case the confocal image 
of equatorial optical slice through fluorescent beads. For details see text. 
and predetermined spectral lineshapes, in our case spectral lineshapes are analyzed in terms of 
wavelengths  of  maximal  intensities  λmax.  While  in  the  first  case  the  derived  weights  are 
directly encoded by the RGB colors, in our case spectral maxima are transformed into colors 
using the  hue rule characterizing changed local concentration or environment  when using 
environmentally sensitive probes. The two approaches are therefore complementary – the first 
one enables spectral decomposition and concentration detection, while the latter enables the 
characterization of small changes in environment detected by one probe only. 
The main benefit of the color coding is a fast recognition of spectral variations across the 
image. Similar spectral contrasting approaches have been utilized in other microspectroscopic 
techniques, for instance in fluorescence lifetime imaging microscopy (FLIM), where an image 
can be color-coded in a way to highlight the different fluorescence lifetimes in different parts 
of the sample [26]. Another example is spectrally resolved anisotropy imaging, where the 
degree of fluorescence anisotropy is used for the color coding [27]. 
3.2. Study of polymer nanoparticles delivery into cancer cells 
Spatially-resolved spectral analysis, which is enabled through the FMS system, allowed us to 
track nanoparticles' delivery/uptake into cancer cells. Firstly, experiments with incubation of 
cells with polymer nanoparticles of two different diameters (50 and 500 nm) were performed. 
After the initial incubation with nanoparticles the lipophilic NBD-FA probe was added to 
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enable  co-localization  of  nanoparticles  with  plasma  membrane  and  cell  inner  membrane 
structures. In our case the emission spectra of fluorescent labels attached to nanoparticles and 
labels  introduced  in  cell  membranes  overlap.  Therefore,  the  use  of  FMS  and  spectral 
contrasting enables to identify and spatially distinguish the two labels. 
In the intensity confocal images the interior of the cells fluoresces (Figs. 3a.1–3c.1), but it 
is not possible to determine the origin of this fluorescent light, i.e. whether it comes from 
nanoparticles or lipophilic probe, except for the aggregated nanoparticles. It can also be seen 
from comparison of images taken in the wide-field and confocal mode (Figs. 3a and 3b) that 
in the wide-field mode the regions rich in the membrane probe seem larger due to the out-of-
focus light coming from the membranes above and below the focal plane. 
On the contrary, the color-coded images in Figs. 3b.2 and 3c.2 clearly show the difference 
in  behavior  between  nanoparticles  of  different  size.  It  can  be  seen  that  only  50  nm 
nanoparticles were transferred in the interior of cells after 25 minutes of incubation (Fig. 
3b.2), while the 500 nm nanoparticles, even after 2 hours, remained outside the cells (Fig. 
3c.2). Co-localization was enabled through spectral identification despite substantial spectral 
overlap of the probes on the nanoparticles and in cell membranes (Fig. 3b.2). If quantitative 
information is desired about the overlapping probes, one should apply the method of linear 
unmixing [15,23,28]. 
3.3. Study of lipid nanoparticles delivery into cancer cells 
Although confocal fluorescence microscopy was previously used to test OPP liposomes as 
drug nanocarriers [29], it did not reveal the mechanism of OPP liposomes delivery across 
plasma membrane. For optimization of the liposomes' properties for even larger cancerostatic 
efficiency, FMS was applied to study living cancer cells exposed to OPP lipid nanoparticles. 
OPP liposomes were labeled with the environment-sensitive NBD-PC fluorescent probe. Note 
that the cells were not labeled. 
NBD is an example of a solvatochromic dye that can exhibit shifts in its emission spectra 
as a function of polarity and hydration of its environment [30]. Consequently, any fusion of 
the OPP liposomes with different amount of cholesterol relative to the cancer cell membrane 
should lead to a change in the lipid environment of the NBD-PC probe. This should induce a 
shift  in  the  λmax  of  the  corresponding  emission  spectrum,  since  the  level  of  cholesterol 
influences the polarity and hydration profile in the membrane [31]. The ability of the FMS of 
spatially-resolved  spectral  analysis  was  therefore  used  to  trace  the  fusion  of  cancer  cell 
membranes and OPP liposomes with different OPP/cholesterol ratios, referred to as OPP5 (29 
mol% Chol) and OPP15 (56 mol% Chol). 
First the environmental sensitivity of NBD-PC was examined in the case of pure liposome 
samples. The images were acquired with FMS and objective lens with 10x magnification. The 
spectra were obtained by averaging the signal from the whole image. The lower magnification 
and averaging was applied in order to reproduce experimental conditions in measurements 
with fluorimeter. The results showed that the spectrum of OPP15 LUV is shifted to lower 
wavelengths  for  about  5  nanometers  compared  to  the  spectrum  of  OPP5  LUV  (data  not 
shown). This result was confirmed also by reference measurements on fluorimeter. 
The reference spectra of liposomes were acquired with FMS and objective lens with 100x 
magnification also on mixture of cells and liposomes. For this purpose, images were spectrally 
analyzed in the regions outside the cells, where intact liposomes that do not interact with cells 
are present. These regions are depicted by the open green square for OPP5 liposomes in Fig. 
4a.4  and  by  the  open  dark  blue  square  for  OPP15  nanoparticles  in  Fig.  4b.4.  Value  of 
λmax(hist) for intact OPP5 liposomes obtained from the histogram in Fig. 4 (green columns) is 
downshifted for about 3 nm with respect to intact OPP15 liposomes (dark blue columns). The 
shift qualitatively confirms the observations for pure liposome samples. The difference in the 
measured  shifts  arises  from  different  experimental  conditions.  Especially,  photobleaching, 
which is intensified when the lens with 100x magnification is used compared to the lens with 
10x magnification, imposes additional uncertainty to the absolute value of λmax. 
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Fig. 3. Interaction of polystyrene nanoparticles with living MCF-7 human breast cancer cells. 
Images of cells incubated in vitro with NBD-FA probe, i.e. a lipophilic NBD based fluorescent 
probe, and with (a) fluorescent 50 nm polymer nanoparticles imaged in wide-field mode or (b) 
imaged in confocal mode and with (c) 500 nm nanoparticles imaged in confocal mode. (a.1, 
b.1,  c.1)  Fluorescence  intensity  contrasted  images.  Fluorescent  emission  spectra  of  the 
nanoparticles and the lipophilic probe overlap, so it is not possible to determine the delivery 
efficiency  of  nanoparticles  to  the  cancer  cells  from  microscopic  image,  except  for  the 
aggregated  nanoparticles  indicated  by  arrows.  (a.2,  b.2,  c.2)  Spectrally  contrasted  images, 
which show the distribution of the NBD-FA probe (green/yellow) and fluorescein (violet/blue). 
The observed colors correspond to the measured (537 nm) and declared (shoulder at 515 nm) 
emission maximum values for membrane and nanoparticle probe, respectively. 
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Fig. 4. Interaction of OPP lipid nanoparticles with living MCF-7 human breast cancer cells. 
Cells incubated in vitro with (a) 100 nm OPP5 LUV labeled with NBD-PC or with (b) labeled 
OPP15 LUV. (a.1-a.3, b.1-b.3) The time evolution of the intensity contrasted images of the 
cancer cells. (a.4, b.4) Color-coded images corresponding to the last image in the time line. 
Between the two color-coded images the histogram of the distribution of fitted spectrum peak 
positions (λmax) from the accordingly-colored squared regions in a.4 and b.4 are shown. The 
histogram confirms the significance of the observed small shifts in the λmax(hist) value. 
The  relatively  small  observed  shift  between  spectra  of  OPP  liposomes  with  different 
amount of cholesterol ascertains the need of a narrow band pass filter system, which would 
not  be  required  for  well  separated  spectra.  In  the  latter  case  two  different 
excitation/dichroic/emission filter combination can be used and subsequently the integrated 
fluorescence  emission  intensities  can  be  compared  for  the  two  combinations.  Such  an 
approach is used in ratiometric or generalized polarization measurements [30,32,33]. 
To  trace  the  interaction  of  the  OPP  liposomes  with  the  living  cancer  cells,  the  time 
evolution of the delivery was followed. It seems that OPP5 gradually accumulate in the cells 
(compare  Fig.  4a.1  to  Fig.  4a.3).  On  the  other  hand,  OPP15  did  neither  interact  nor 
accumulate in cells (Fig. 4b.1 to Fig. 4b.3). This confirms that the efficiency of delivery 
depends on the amount of cholesterol in OPP liposomes, which is in agreement with our 
previous results obtained by electron paramagnetic resonance [4]. Lack of OPP15 liposomes 
accumulation in the cells means that these liposomes are spread and diluted all-around the 
cells, significantly increasing out-of-focus light and thus decreasing the contrast in confocal 
mode. Together with low intensity (low signal to noise ratio) this forced us to show the wide-
field image for OPP15. To enable better comparison with OPP5 also the latter is shown in the 
wide-field  mode,  although  we  obtained  also  confocal  FMS  data..  For  this  particular 
#146260 - $15.00 USD Received 21 Apr 2011; revised 3 Jun 2011; accepted 27 Jun 2011; published 29 Jun 2011
(C) 2011 OSA 1 August 2011 / Vol. 2,  No. 8 / BIOMEDICAL OPTICS EXPRESS  2094   
experiment this did not impose a limitation, while the spectral information was collected from 
a larger spatial region of the sample, as discussed below. 
Finally, FMS reveals much more than just information on the accumulation of the particles 
within the cells. It is also possible to see a change in spectral properties of NBD-PC from the 
color-coded image of cancer cells exposed to OPP5 liposomes. Specifically, there is a spectral 
shift between the spectra of the probe residing inside the cell (Fig. 4a.4, area depicted by the 
open light blue square) or in intact free liposomes (Fig. 4a.4, area depicted by the open green 
square). The analysis of the distribution of fitted spectrum peak positions λmax, shown in a 
histogram, clearly reveals the shift of 1 nm, which is significant although very small (compare 
the center of mass for green and light blue columns in the histogram in Fig. 4). Note that the 
increased accuracy of determining spectral maximum position is analogous to an increased 
positional  accuracy  in  single  molecule  tracking  (see  Section  2.5  for  details).  Since  the 
spectrum of NBD-PC depends on the properties of lipid environment as already corroborated 
above, it is possible to assign the spectral shift to a change in the probe environment. The 
main  reason  for  this  change  is  mainly  due  to  direct  interaction  of  liposomes  with  cell 
membrane, e.g. through membrane fusion. In contrast, the analysis of the OPP15 liposomes 
data shows no significant difference in the spectral properties across the image (Fig. 4b.4). 
Due to the wide-field mode, which imposes a large portion of out-of-focus light, we can see 
the same (weak) spectrum all over the image. 
The presented example clearly shows the strength of the FMS approach in the study of the 
mechanism  of  nanoparticles  interaction  with  cancer  cells.  Similarly  to  lipid-based 
nanoparticles, the usefulness of the FMS approach to study drug delivery to cancer cells was 
also shown for metal-based nanoparticles [34]. 
4. Conclusions 
Different nanoparticles are increasingly being used in cancer therapy because of their passive 
targeting to cancer cells by enhanced permeability and retention effect. The results presented 
in the current work show that the developed modular fluorescence microspectroscopy system 
can serve as a useful biomedical tool to study and screen the  mechanisms of delivery of 
different fluorescently labeled nanoparticles to living cancer cells. Firstly, FMS enables co-
localization of inner cancer cell membranes and cell-entering polymer nanoparticles that are 
labeled with spectrally overlapping fluorophores. Secondly, FMS made it possible to detect a 
small  shift  in  the  fluorescence  emission  spectrum  maximum,  which  was  attributed  to  the 
fusion of labeled lipid nanoparticles with cancer cell membranes. In addition, the built system 
represents  a  diverse  tool  for  research  of  fluorescently  labeled  biological  systems,  e.g.  for 
monitoring  biophysical  properties  of  lipid  membranes  by  environmentally  sensitive 
fluorescent probes. 
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